Showing 5851-5860 of 7022 results for "".
- Scaravoid May Offer A New Approach to Wound Healinghttps://practicaldermatology.com/news/scaravoid-may-offer-a-new-approach-to-wound-healing/2460126/A new foam that is placed in skin wounds to support and optimize the natural healing process may help prevent scarring. With the "Scaravoid" project, Markus Rottmar, PhD and his team at Empa's Biointerfaces lab
- NRS Releases New Free Resource for Rosacea Patientshttps://practicaldermatology.com/news/nrs-releases-new-free-resource-for-rosacea-patients/2460125/The National Rosacea Society new public service booklet, “Recognizing Redness”, is now available. The free booklet includes a redness register to allow patients to gauge relative redness
- Soliton Treats First Patients in Cellulite Trialhttps://practicaldermatology.com/news/soliton-treats-first-patients-in-cellulite-trial/2460124/The first patients in Soliton’s cellulite trial have been treated, the Company reports. "Patient treatments have now begun at the Chicago site,” says Dr. Chris Capelli, President, CEO and co-founder of Soliton, in a ne
- PE in Dermatology: NavaDerm Partners with Laser & Skin Surgery Center of NYhttps://practicaldermatology.com/news/pe-in-dermatology-navaderm-partners-with-laser-skin-surgery-center-of-ny/2460119/NavaDerm is partnering with Laser & Skin Surgery Center of New York, Midtown Dermatology and their affiliated entities. Navaderm is a dermatology services organization in the Northeast and a BelHealth Investm
- Complete Wound Healing Seen on Index Lesion of the First Subject in an Ongoing Phase 2 Trial of RGN-137 Dermal Gel for EBhttps://practicaldermatology.com/news/complete-wound-healing-seen-on-index-lesion-of-the-first-subject-in-an-ongoing-phase-2-trial-of-rgn-137-dermal-gel-for-eb/2460118/Lenus Therapeutics, LLC, a US-based joint venture between GtreeBNT and Yuyang DNU in Korea, has confirmed complete wound healing of the index lesion of the first subject enrolled in its ongoing single-masked Phase 2 clinical trial with RGN-137 dermal gel for Epidermolysis Bullosa (EB).
- Psoriasis Therapy Linked to Reduced Coronary Inflammationhttps://practicaldermatology.com/news/psoriasis-therapy-linked-to-reduced-coronary-inflammation/2460112/Anti-inflammatory biologic therapies used to treat moderate to severe psoriasis can significantly reduce coronary inflammation in patients with the chronic skin condition. Scientists said the findings are particularly notable because of the use of a novel imaging biomarker, the perivascular fat a
- Sciton Targets Veins, Skin, and Hair with Clear Suitehttps://practicaldermatology.com/news/sciton-targets-veins-skin-and-hair-with-clear-suite/2460111/Sciton Inc. is launching its Clear Suite family of products. The Clear Suite offerings make the JOULE platform customizable. Utilizing the 1064 Nd:YAG wavelength, the Clear Suite family of products, including ClearV, ClearSilk, and ClearHair, combined with BroadBand Light (BBL), al
- New Cerave Poll Reveals Confusion about Healthy, Clean Skin and How to Achieve Ithttps://practicaldermatology.com/news/new-cerave-poll-reveals-confusion-about-healthy-clean-skin-and-how-to-achieve-it/2460108/Many of us are confused about what "clean" skin really means and how best to achieve it, according to an online survey commissioned by CeraVe.
- Summer AAD News: Dramatic Spike in Female Skin Cancer Linked to Tanninghttps://practicaldermatology.com/news/summer-aad-news-dramatic-spike-in-female-skin-cancer-linked-to-tanning/2460105/Skin cancer in women is on the rise, and indoor tanning may be to blame, according to new research presented at the 2019 American Academy of Dermatology Summer Meeting in New York City. Between 1970 and 2009, rates of melanoma increased 800 percent among women ages 18-39, making it the
- Psoriasis, Psoriatic Arthritis, and AD Updates from Day 1 at DERM2019https://practicaldermatology.com/news/psoriasis-psoriatic-arthritis-and-ad-updates-from-day-1-at-derm2019/2460098/The first day of the DERM2019 NP/PA CME Conference kicked off with a bang! Exciting talks and lively panel discussions from April Armstrong, David Cohen, Adam Friedman, Kara Gooding, and Joe Gorelick were the mainstay of the day. Psoriasis Pathogenesis and Treatment T